Thematic Pillar Hub · 2 Published Briefings
regulatory-compliance institutional intelligence, quantitative benchmarks, primary regulatory filings, and market structure analysis from Sovereign Tax Atlas. The Federal Reserve Board will remove the 'Build Your Package' (BYP) option from the Data Download Program (DDP) during the week of November 9, as part of preparations for the DDP's eventual full retirement. Affected users are directed to FRED or XML-format downloads as replacement data access methods.
Curated by Dr. Geneviève Laurent, LL.M, CTA (LL.M in International Taxation (NYU), Chartered Tax Adviser (CTA)) · Fact-checked by Sovereign Tax Atlas Institutional Review Board
The Federal Reserve Board will remove the 'Build Your Package' (BYP) option from the Data Download Program (DDP) during the week of November 9, as part of preparations for the DDP's eventual full retirement. Affected users are directed to FRED or XML-format downloads as replacement data access methods.
The Trump administration has announced it will not take enforcement action against compounding pharmacies manufacturing six popular peptide wellness products, including BPC-157 and TB-500, clearing a significant regulatory pathway for these compounds.
The BYP option is defined as a self-service feature within the Federal Reserve Board's Data Download Program (DDP) that allows users to select and bundle specific data series into a custom downloadable package. It is being removed during the week of November 9 as part of the Board's efforts to streamline data offerings in preparation for the eventual retirement of the DDP (Source: Federal Reserve Board, federalreserve.gov).
Users relying on BYP should migrate their workflows to either FRED (Federal Reserve Economic Data, operated by the Federal Reserve Bank of St. Louis) or begin using the newly added XML-format release downloads available on DDP release pages. Both options were confirmed as available in the Federal Reserve Board's announcement (Source: federalreserve.gov, week of November 9).
Not entirely. The XML-format download provides a structured, machine-readable full release file from DDP release pages, but does not replicate the custom package-building capability of BYP. For custom data selection and bundling equivalent to BYP, the Federal Reserve Board directs users to FRED (Source: Federal Reserve Board, federalreserve.gov). The XML option serves users who prefer direct bulk file downloads.
The Trump administration has stated it will not take enforcement action against compounding pharmacies that manufacture six specific peptide wellness products, including BPC-157 and TB-500 (Source: MarketWatch, 2025). This is enforcement discretion, not formal FDA approval — the underlying regulatory framework has not changed, and these compounds remain unapproved drugs under federal law.
No. Enforcement discretion is defined as a regulatory agency's decision to refrain from pursuing legal action without altering the statutory framework. BPC-157 and TB-500 have not undergone the FDA's standard new drug approval process and are not FDA-approved drugs. Compounding pharmacies producing them still operate under existing compounding regulations and state pharmacy board requirements.
The imported snapshot entry labeled 'BPC (Backpacker Coin)' with an imported score of 1.0/10 and risk field 'unknown' appears to refer to a separate, unrelated entity and not to the pharmaceutical peptide BPC-157. The snapshot contained no license record for this entry, and it has not been independently verified against any current official regulatory register. It should not be treated as proof of authorization, current license status, or an official warning regarding any entity.
